Ed. note: Welcome to our daily feature, Quote of the Day.
I’m definitely talking to general counsel who are using the settlement issue as a criteria—if not a dispositive variable—in their law firm choices. We haven’t pulled work from any firms yet, but when new matters come up, we’re making sure that firms challenged by the government have a real opportunity to win our business.
— Eric Whitaker, chief legal officer at DNA sequencing company 10X Genomics, in comments given to the American Lawyer, concerning working with law firms that made deals with the Trump administration. “There’s a range of day-to-day legal work where I have complete discretion–and that’s where you’ll see movement first,” he said, pointing out that “there’s a real concern about institutional stability.” He went on to say that “[i]f a firm you’ve invested in suddenly can’t represent you because of outside pressure, that’s a major problem for companies.” Whitaker is the co-founder of GCs United, a group for in-house legal officers to “unite in support of the rule of law and fellow lawyers.”
Staci Zaretsky is the managing editor of Above the Law, where she’s worked since 2011. She’d love to hear from you, so please feel free to email her with any tips, questions, comments, or critiques. You can follow her on Bluesky, X/Twitter, and Threads, or connect with her on LinkedIn.
The post Corporate Clients Aren’t Just Going To Forget About The Biglaw Firms That Made Deals With Trump appeared first on Above the Law.